将可扩展的基因组测序整合到微生物实验室以进行常规抗菌药物耐药性监测
抗菌药物耐药性(AMR)监测目前依赖表型鉴定,但可扩展性差。为建立基于全基因组测序(WGS)的全球AMR监测,作者在哥伦比亚、印度、尼日利亚和菲律宾4个单元实施了实验室实施路径,分评估、组装、优化和再评估4个阶段。结果显示,尽管实验室基础设施和维护初始投资高,WGS能力可大幅增强区域和国家AMR监测的实时处理能力。
要点
- WGS可增强AMR监测的表型数据,但实验室基础设施和维护初始投资高。
- WGS能力建设分评估、组装、优化和再评估4个阶段。
- 有意引入WGS作为监测工具的国家可先从测序选定的GLASS优先病原体开始。
核心结论
- 尽管实验室基础设施和维护初始投资高,WGS能力可大幅增强区域和国家AMR监测的实时处理能力。
- 有意引入WGS作为监测工具的国家可先从测序选定的GLASS优先病原体开始,以展示标准化和基因组测序在应对AMR中的影响。
研究设计与样本
- 作者在NIHR全球健康研究单位(GHRU)抗菌药物耐药性基因组监测项目中开发并应用了实验室实施方法。
- 在哥伦比亚、印度、尼日利亚和菲律宾4个单元概述了实验室实施情况。
主要发现
- 将WGS能力嵌入的历程分为4个阶段:评估、组装、优化和再评估。
- WGS能力建设可大幅增强区域和国家AMR监测举措中的实时处理能力。
临床怎么用
- 有意引入WGS作为监测工具的国家可先从测序选定的GLASS优先病原体开始。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial resistance (AMR) is considered a global threat, and novel drug discovery needs to be complemented with systematic and standardized epidemiological surveillance. Surveillance data are currently generated using phenotypic characterization. However, due to poor scalability, this approach does little for true epidemiological investigations. There is a strong case for whole-genome sequencing (WGS) to enhance the phenotypic data. To establish global AMR surveillance using WGS, we developed a laboratory implementation approach that we applied within the NIHR Global Health Research Unit (GHRU) on Genomic Surveillance of Antimicrobial Resistance. In this paper, we outline the laboratory implementation at 4 units: Colombia, India, Nigeria, and the Philippines. The journey to embedding WGS capacity was split into 4 phases: Assessment, Assembly, Optimization, and Reassessment. We show that on-boarding WGS capabilities can greatly enhance the real-time processing power within regional and national AMR surveillance initiatives, despite the high initial investment in laboratory infrastructure and maintenance. Countries looking to introduce WGS as a surveillance tool could begin by sequencing select Global Antimicrobial Resistance Surveillance System (GLASS) priority pathogens that can demonstrate the standardization and impact genome sequencing has in tackling AMR.
引用
- Kekre M, Arevalo SA, Valencia MF, et al. Integrating Scalable Genome Sequencing Into Microbiology Laboratories for Routine Antimicrobial Resistance Surveillance. Clin Infect Dis. 2021. PMID: 34850836. doi:10.1093/cid/ciab796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。